GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Meridian Bioscience Inc (LTS:0K0K) » Definitions » Operating Margin %

Meridian Bioscience (LTS:0K0K) Operating Margin % : 14.18% (As of Sep. 2022)


View and export this data going back to 2018. Start your Free Trial

What is Meridian Bioscience Operating Margin %?

Operating Margin % is calculated as Operating Income divided by its Revenue. Meridian Bioscience's Operating Income for the three months ended in Sep. 2022 was $9.3 Mil. Meridian Bioscience's Revenue for the three months ended in Sep. 2022 was $65.7 Mil. Therefore, Meridian Bioscience's Operating Margin % for the quarter that ended in Sep. 2022 was 14.18%.

The historical rank and industry rank for Meridian Bioscience's Operating Margin % or its related term are showing as below:


LTS:0K0K's Operating Margin % is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: -5.375
* Ranked among companies with meaningful Operating Margin % only.

Meridian Bioscience's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

Meridian Bioscience's Operating Income for the three months ended in Sep. 2022 was $9.3 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Sep. 2022 was $75.2 Mil.


Meridian Bioscience Operating Margin % Historical Data

The historical data trend for Meridian Bioscience's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Meridian Bioscience Operating Margin % Chart

Meridian Bioscience Annual Data
Trend Sep13 Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22
Operating Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18.86 18.58 24.32 30.30 22.81

Meridian Bioscience Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.43 22.96 32.55 13.81 14.18

Competitive Comparison of Meridian Bioscience's Operating Margin %

For the Diagnostics & Research subindustry, Meridian Bioscience's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Meridian Bioscience's Operating Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Meridian Bioscience's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Meridian Bioscience's Operating Margin % falls into.



Meridian Bioscience Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Meridian Bioscience's Operating Margin % for the fiscal year that ended in Sep. 2022 is calculated as

Operating Margin %=Operating Income (A: Sep. 2022 ) / Revenue (A: Sep. 2022 )
=75.95 / 333.018
=22.81 %

Meridian Bioscience's Operating Margin % for the quarter that ended in Sep. 2022 is calculated as

Operating Margin %=Operating Income (Q: Sep. 2022 ) / Revenue (Q: Sep. 2022 )
=9.311 / 65.675
=14.18 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Meridian Bioscience  (LTS:0K0K) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Meridian Bioscience Operating Margin % Related Terms

Thank you for viewing the detailed overview of Meridian Bioscience's Operating Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Meridian Bioscience (LTS:0K0K) Business Description

Traded in Other Exchanges
N/A
Address
3471 River Hills Drive, Cincinnati, OH, USA, 45244
Meridian Bioscience Inc is an integrated life science company. It develops and distributes diagnostic tests and reagents, as well as biologic substances used by pharmaceutical and biotechnology companies. Its Diagnostics segment manufactures tests primarily for gastrointestinal, viral, respiratory, & parasitic infectious diseases. Its testing platforms include isothermal DNA amplification, rapid immunoassays, and enzyme-linked immunoassays. The Life sciences segment sells b-antigens, antibodies, and reagents in bulk to other diagnostic manufacturers, the agriculture industry, and researchers. It also manufactures proteins that biopharmaceutical companies use in new drugs and vaccines. The entity has a business presence in the US and other countries.

Meridian Bioscience (LTS:0K0K) Headlines

No Headlines